According to an update released by analysts at RBC Capital Markets the broker has now set a ‘Outperform’ rating on shares of Acadia Healthcare Company (NASDAQ:ACHC) with a price target of 59.
RBC Capital Markets on Wednesday reiterated Acadia Healthcare Company’s analyst rating as ‘Outperform’ with its price target of 59 highlighting a potential increase of 50.7% from Acadia Healthcare Company’s current price of 39.15.
Over the last twelve months Acadia Healthcare Company’s stock price has decreased from 64.5 to 39.15, a change of -39.3%.
Acadia Healthcare Company has 87,416,000 shares in issue which have a share price of 39.15 giving Acadia Healthcare Company a market capitalisation of 3.42B USD.
The company has a 50 day moving average of 49.05 and a 200 day moving average of 54.52. The 52 week high shares of Acadia Healthcare Company have reached is 74.77 whilst the 52 week low for the company’s shares is 37.96.
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico. The Company operates approximately 260 behavioral healthcare facilities with over 9,900 beds in over 40 states, the United Kingdom and Puerto Rico. Its U.S. facilities and services are classified into categories, which include acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers and outpatient community-based services. It provides inpatient services through mental health hospitals and care homes in the United Kingdom.